PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists discover how deadly skin cancer spreads into other parts of the body

Scientists discover how deadly skin cancer spreads into other parts of the body
2013-01-04
(Press-News.org) After recently announcing success in eliminating melanoma metastasis in laboratory experiments, scientists at Virginia Commonwealth University Massey Cancer Center have made another important discovery in understanding the process by which the gene mda-9/syntenin contributes to metastasis in melanoma (the spread of skin cancer) and possibly a variety of other cancers.

Published in the journal Cancer Research, the study demonstrated that mda-9/syntenin is a key regulator of angiogenesis, the process responsible for the formation of new blood vessels in tumors. Mda-9/syntenin was originally cloned in the laboratory of the study's lead author Paul B. Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research and program co-leader of Cancer Molecular Genetics at Virginia Commonwealth University Massey Cancer Center, chairman of VCU's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine.

"Our research brings us one step closer to understanding precisely how metastatic melanoma, a highly aggressive and therapy-resistant cancer, spreads throughout the body," says Fisher. "Additionally, analysis of the human genome has indicated that mda-9/syntenin is elevated in the majority of cancers, which means novel drugs that target this gene could potentially be applicable to a broad spectrum of other deadly cancers."

Fisher's team discovered that mda-9/syntenin regulates the expression of several proteins responsible for promoting angiogenesis, including insulin growth factor binding protein-2 (IGFBP-2) and interleukin-8 (IL-8). The study is the first to provide proof of the pro-angiogenic functions of IGFBP-2 in human melanoma.

In in vivo and in vitro experiments, the scientists confirmed that mda-9/syntenin binds with the extracellular matrix (ECM) to start a series of biological processes that eventually cause endothelial cells to secrete IGFBP-2. The ECM is the substance that cells secrete and in which they are embedded. Endothelial cells are the cells that line the interior surface of blood vessels throughout the entire circulatory system. The secretion of IGFBP-2, in turn, caused the endothelial cells to produce and secrete vascular endothelial growth factor-A (VEGF-A), a protein that mediates the development of and formation of new blood vessels.

The researchers also noted that IGFBP-2 could potentially serve as a novel biomarker to monitor for disease progression in melanoma patients.

"This is a major breakthrough in understanding angiogenesis and its impact in melanoma metastasis," says Fisher. "We are now focusing on developing novel small molecules that specifically target mda-9/syntenin and IGFBP-2, which could be used as drugs to treat melanoma and potentially many other cancers."



INFORMATION:

Fisher collaborated on this study with Devanand Sarkar, M.B.B.S., Ph.D., Harrison Scholar and research member of the Cancer Molecular Genetics program at VCU Massey, Blick Scholar and assistant professor in the Department of Human and Molecular Genetics and member of the VCU Institute of Molecular Medicine at VCU School of Medicine; Swadesh K. Das, Ph.D., Santanu Dasgupta, Ph.D., and Luni Emdad, M.B.B.S., Ph.D., from the Department of Human and Molecular Genetics at VCU School of Medicine, the VCU Institute of Molecular Medicine and the Cancer Molecular Genetics research program at VCU Massey; Sujit K. Bhutia, Ph.D., Belal Azab, Ph.D., Upneet K. Sokhi, Timothy P. Kegelman, Leyla Peachy, Prasanna K. Santhekadur, Ph.D., and Rupesh Dash, Ph.D., all from the Department of Human and Molecular Genetics; Paul Dent, Ph.D., Universal Corporation Distinguished Professor for Cancer Cell Signaling and Developmental Therapeutics program member at VCU Massey, and professor and vice chair of research in the Department of Neurosurgery at VCU School of Medicine; Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, program co-leader of the Developmental Therapeutics program and Cancer Cell Signaling program member at VCU Massey; and Maurizio Pellacchia, Ph.D., from Sanford-Burnham Medical Research Institute.

This research was supported by National Institutes of Health grant CA097318, the Thelma Newmeyer Corman Endowment, the National Foundation for Cancer Research, the Goldhirsh Foundation for Brain Tumor Research, the Dana Foundation and, in part, by funding from VCU Massey Cancer Center's NIH-NCI Cancer Center Support Grant P30 CA016059.

The full manuscript of this study is available online at: http://cancerres.aacrjournals.org/content/early/2012/12/08/0008-5472.CAN-12-1681.long

News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact John Wallace, (804) 628-1550.

About VCU Massey Cancer Center

VCU Massey Cancer Center is one of only 67 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It has one of the largest offerings of clinical trials in Virginia and serves patients in Richmond and in four satellite locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately to cure cancer. Visit Massey online at www.massey.vcu.edu or call 877-4-MASSEY for more information.

About VCU and the VCU Medical Center

Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 222 degree and certificate programs in the arts, sciences and humanities. Sixty-six of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.


[Attachments] See images for this press release:
Scientists discover how deadly skin cancer spreads into other parts of the body

ELSE PRESS RELEASES FROM THIS DATE:

Liquid jets and bouncing balls combine for surprising results

2013-01-04
A new study published in the American Institute of Physics' (AIP) journal Physics of Fluids reveals that the normal rebounding of a ball changes when it is partially filled with a liquid. Unlike an empty sphere or a solid rubber ball, which both rebound in a classical and well-understood fashion, a fluid-filled ball has its second bounce remarkably cut short. A team of researchers from Brigham Young University in Provo, Utah, uncovered this phenomenon when they investigated what would happen if a sphere were partially filled with a liquid and how that would affect the way ...

Power spintronics: Producing AC voltages by manipulating magnetic fields

2013-01-04
Scientists are putting a new spin on their approach to generating electrical current by harnessing a recently identified electromotive force known as spinmotive force, which is related to the field of spintronics that addresses such challenges as improving data storage in computers. Now, a novel application of spintronics is the highly efficient and direct conversion of magnetic energy to electric voltage by using magnetic nanostructures and manipulating the dynamics of magnetization. According to a report published in the American Institute of Physics' (AIP) journal Applied ...

UC Davis study links low wages with hypertension, especially for women and younger workers

2013-01-04
(SACRAMENTO, Calif.) — Workers earning the lowest wages have a higher risk of hypertension than workers with the highest wages, according to new research from UC Davis. The correlation between wages and hypertension was especially strong among women and persons between the ages of 25 to 44. "We were surprised that low wages were such a strong risk factor for two populations not typically associated with hypertension, which is more often linked with being older and male," said J. Paul Leigh, senior author of the study and professor of public health sciences at UC Davis. ...

Sorting stem cells

2013-01-04
When an embryonic stem cell is in the first stage of its development it has the potential to grow into any type of cell in the body, a state scientists call undifferentiated. A team of researchers from Scotland has now demonstrated a way to easily distinguish undifferentiated embryonic stem cells from later-stage stem cells whose fate is sealed. The results are published in the American Institute of Physics' (AIP) journal Biomicrofluidics. The researchers used an electric field to pull stem cells through a fluid in a process called dielectrophoresis. They varied the frequency ...

New understanding of nerve damage caused by spinal cord injury could improve treatment design

New understanding of nerve damage caused by spinal cord injury could improve treatment design
2013-01-04
New Rochelle, NY, January 3, 2013—More than half of traumatic spinal cord injuries (SCI) in humans are cervical lesions, resulting in chronic loss of limb function. A better understanding of the link between the neurologic damage caused by SCI, spontaneous motor function recovery, and long-term motor deficits would lead to better therapeutic approaches, as discussed in an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Neurotrauma website at http://www.liebertpub.com/neu. About ...

Carbon in Vesta's craters

Carbon in Vestas craters
2013-01-04
The protoplanet Vesta has been witness to an eventful past: images taken by the framing camera onboard NASA's space probe Dawn show two enormous craters in the southern hemisphere. The images were obtained during Dawn's year-long visit to Vesta that ended in September 2012. These huge impacts not only altered Vesta's shape, but also its surface composition. Scientists under the lead of the Max Planck Institute for Solar System Research in Katlenburg-Lindau in Germany have shown that impacting small asteroids delivered dark, carbonaceous material to the protoplanet. In the ...

Planets abound

Planets abound
2013-01-04
PASADENA, Calif.—Look up at the night sky and you'll see stars, sure. But you're also seeing planets—billions and billions of them. At least. That's the conclusion of a new study by astronomers at the California Institute of Technology (Caltech) that provides yet more evidence that planetary systems are the cosmic norm. The team made their estimate while analyzing planets orbiting a star called Kepler-32—planets that are representative, they say, of the vast majority in the galaxy and thus serve as a perfect case study for understanding how most planets form. "There's ...

Improving DNA amplification from problematic plants

2013-01-04
The polymerase chain reaction (PCR) is a common technique used to amplify, or copy, pieces of DNA. Amplified DNA is then used in genetic analyses for everything from medicine to forensics. In plant research, PCR is a vital step in detecting and sequencing genes, and its applications are endless. However, compounds found in plants often inhibit PCR. Researchers at the University of Southern Mississippi discovered that the use of an additive allows PCR to successfully amplify DNA from once problematic plants. PCR is widely used in plant sciences but is not 100 percent ...

Plvap/PV1 critical to formation of the diaphragms in endothelial cells

2013-01-04
PV1 expression in vascular endothelium is required for survival PV1 is required for the formation of stomatal and fenestral diaphragms Lack of diaphragms in fenestrated endothelia causes vascular leak of plasma proteins Vascular leak results in severe hypoproteinemia and hypertriglyceridemia Dartmouth scientists have demonstrated the importance of the gene Plvap and the structures it forms in mammalian physiology in a study published in December by the journal Developmental Cell. "The knowledge generated and the animal models created will allow a better understanding ...

Finding Chicago's food gardens with Google Earth

2013-01-04
Urban agriculture is promoted as a strategy for dealing with food insecurity, stimulating economic development, and combating diet-related health problems in cities. However, up to now, no one has known how much gardening is taking place in urban areas. Researchers at the University of Illinois have developed a methodology that they used to quantify the urban agriculture in Chicago. John Taylor, a doctoral candidate working with crop sciences researcher Sarah Taylor Lovell, was skeptical about the lists of urban gardens provided to him by local non-governmental organizations ...

LAST 30 PRESS RELEASES:

Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds

Measuring the properties of light: Scientists realise new method for determining quantum states

For faster access to gene and cell therapies in Europe

Scientists deliver portable total chemical analysis without pumps and tubes

A very long, winding road: Developing novel therapeutics for metastatic tumors

Unlocking health: How In Our DNA SC is pioneering genetic screening for South Carolinians

Down Under Demo: ONR touts additive manufacturing tech at Australian event

Study shows benralizumab is effective as a treatment for eosinophilic granulomatosis with polyangiitis, a rare form of vasculitis

Researchers identify new choice of therapy for rare autoimmune disease EGPA

Powering nitrogenases

NJIT marketing experts measure brain waves and skin current to predict emotions

Babies use immune system differently, but efficiently

Cloud clustering causes more extreme rain

Mindfulness at work protects against stress and burnout

Scientists closer to solving mysteries of universe after measuring gravity in quantum world

Revolutionary brain stimulation technique shows promise for treating brain disorders

Global warming increases the diversity of active soil bacteria

Patient mindset training helps care teams

Dual-energy harvesting device could power future wireless medical implants

Study: ‘Hexaplex’ vaccine aims to boost flu protection

New structural insights could lead to mechanical enhancement in alloys

New research challenges conventional picture of Parkinson's disease

Dairy cows fed botanicals-supplemented diets use energy more efficiently

Aston University receives nearly half a million pounds to create safer and greener batteries

New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

Sir Peter Rigby appointed as honorary chair of Aston University’s new Digital Futures Institute

Yale School of Medicine receives a $575,000 grant from PolyBio Research Foundation to fund long COVID research

Common plant could help reduce food insecurity, researchers find

Innovative chemotherapy approach shows promise against lung cancer

Encoding computers of the future

[Press-News.org] Scientists discover how deadly skin cancer spreads into other parts of the body